Nuvectis Pharma Stock Forum

$Nuvectis Pharma (NVCT.US)$
Market News Alert: Nuvectis Pharma's NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation
Wednesday, 5th March at 8:44 am
Cleveland Clinic research provides further positive validation Nuvectis Pharma's* NXP900 cancer-fighting potential, showing enhanced efficacy when combined with AstraZeneca's blockbuster drug Tagrisso® in EGFR+ lung cancer models. New $18 price target and buy reco...

$Nuvectis Pharma (NVCT.US)$
Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC
Tuesday, 4th March at 8:00 am
Fort Lee, NJ, March 04, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines...

$Nuvectis Pharma (NVCT.US)$
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2024 AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics

$Nuvectis Pharma (NVCT.US)$
Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
Nuvectis Pharma (NASDAQ: NVCT) has announced that its drug NXP800 has received Orphan Drug Designation from the FDA for treating ARID1a-deficient ovarian, fallopian tube, and primary peritoneal cancers. This designation is significant as ovarian cancer typically exceeds the 200,000 patient thr...

$Nuvectis Pharma (NVCT.US)$what just happened this shot up 50%

$Nuvectis Pharma (NVCT.US)$ 2 fda

$Nuvectis Pharma (NVCT.US)$
- support $10 resistance $12
$RCM Technologies (RCMT.US)$
- support $18.45  resistance $20
$Livent (LTHM.US)$
- Support $27  resistance $30
$Innoviz Technologies (INVZ.US)$
  - support $4.75 Resistance $5.5
$Forge Global (FRGE.US)$
  - support $32 resistance $35